6Next-generation sequencing (NGS) has a huge amount of potential as a critical technology for delivering next-generation healthcare solutions. The dramatic decrease in the cost of genetic profiling and analysis has opened up a plethora of new opportunities in the pharmaceutical and diagnostic industries, particularly in the field of precision medicine. NGS services and informatics businesses have created capabilities in areas such as Cloud computing and Big Data analytics to offer seamless genomic solutions at an optimal cost to meet the ever-growing big genomic data processing and analysis requirements. The majority of these have been centred on critical growth areas like drug development, precision medicine, clinical diagnostics, and multi-omics, among others.Pharmaceuticals and biotech companies have driven an increase in the number of large-scale genome sequencing projects to support their genomics drug development programs. This is predicted to completely alter market dynamics.NGS will continue to become increasingly efficient and affordable, revolutionizing several fields related to genomics. However, as the scope of market applications expands, firms are battling to get approval from pharmaceutical and biotech stakeholders and develop a commercially viable business strategy.This edition of Life Sciences Review brings you the story oftop-in-class Next-Generation Sequencing solution providers that deliver the best outcomes for their clients. This edition also offers thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition of Life Sciences Review, `Top 10 Next-Generation Sequencing Solution Providers ­ 2022' will provide the right assistance in choosing best Next-Generation Sequencing solution provider according to your requirements.Let us know your thoughts!EDITORIALReducing Sequencing Costs with Better Results Copyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com MAY - 19 - 2022, Vol 03, Issue - 04 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comVictor Cruz
< Page 5 | Page 7 >